Navigation Links
EyeLock Inc. Introduces EyeSwipe Nano TS Iris Scanning Turnstile Solution for Secure Access Control
Date:9/10/2012

PHILADELPHIA, Sept. 10, 2012 /PRNewswire/ -- EyeLock Inc., a leading provider of iris-based identity authentication solutions, announced today the launch of its latest product, the EyeSwipe-Nano® TS.  This high throughput iris recognition turnstile device provides one of the most secure access control solutions available. The EyeSwipe Nano TS will be on display at the ASIS International 58th Annual Seminar and Exhibits – the preeminent conference for security professionals – in Philadelphia, Pa. this week from September 10 – 13.

The EyeSwipe-Nano TS is an advanced iris biometric turnstile solution, providing real-time iris capture, at-a-distance and in motion. It has been engineered to meet the needs of turnstile or other rapid-throughput environments and features a broad capture range for enhanced ease-of-use at high speeds. The EyeSwipe Nano TS includes an integrated card reader to support legacy users and smooth transition to iris-based technology.

"In its newest form, our latest product offering containing EyeLock's proven iris authentication technology will further differentiate itself across the access control sector.  The addition of EyeSwipe-Nano TS to our product portfolio enables system integrators around the world to step up their high throughput identity authentication solutions in a more efficient, secure and cost effective way," said Anthony Antolino, Chief Marketing Officer of EyeLock.

As with all EyeLock identity management solutions, the purchase of the EyeSwipe-Nano TS includes enrollment, administrative and matching software, as well as a per unit license for unlimited users. The hardware and software seamlessly integrate with all industry standard access control platforms. EyeSwipe-Nano TS is agnostic and can be coupled with any industry algorithms, and existing databases.

"As a security industry leader, we have seen various security products come onto the market, however, until now, we have not seen a truly seamless identity authentication system that has the ability to transcend vertical markets as much as EyeLock," said John Nemerofsky, Vice President Global Vertical Market Solutions, Stanley Security Solutions. "The EyeLock EyeSwipe-Nano TS is no exception, there is high demand for increased security solutions in high throughput environments and we are confident EyeSwipe Nano TS will be a success with our customers," he said.

The EyeSwipe-Nano TS will be available for purchase through Stanley Security Solutions and will be exhibited at Stanley's ASIS booth #701.

About EyeLock Inc.

EyeLock Inc. is a leading technology provider of iris-based identity management products and technology solutions. Transforming the way identities are authenticated and protected, the Company offers a broad suite of breakthrough solutions for the identity management, access control, border control and logical access sectors.

The proprietary, iris-based identity management solutions are cost-effective, scalable and easy-to-use iris recognition systems that operate while a person is in motion and at a distance. EyeLock delivers products and solutions where privacy, convenience and security are synonymous.

Media Contact:
Samantha Wolf
KCSA Strategic Communications
(212) 896-1220
swolf@kcsa.com

 


'/>"/>
SOURCE EyeLock Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related biology news :

1. Jim Demitrieus, CEO of EyeLock, Invited to White House Cyber Security Event
2. Securiport: Biometric Scanning is Gold Standard in Airport Security
3. 1 solution to global overfishing found
4. High-resolution atomic imaging of specimens in liquid by TEM using graphene liquid cell
5. Bowman provides strategies to engage public with climate change solutions
6. MedNet Solutions to Demonstrate Its Innovative Suite of eClinical Solutions at the 2012 Bio-IT World Conference & Expo
7. University of Minnesota startup offers game-changing energy solutions that reduce CO2 emissions
8. BioLife Solutions Announces 7th Consecutive Quarter of Record Revenue
9. CDS Monarch Deploys DigitalPersona Strong Authentication Solutions for Secure Access to Electronic Medical Records
10. Scientists find gold-plated fossil solution
11. Validity CTO to Present Natural ID Solutions for Improving Mobile Risk Management and User Experience at NFC Solutions Summit 2012
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/2/2017)... JACKSONVILLE, Fla. , Feb. 2, 2017 /PRNewswire/ ... ), a clinical-stage immuno-oncology company specializing in the ... vaccines for the treatment of cancer and metastatic ... multi-gram scale-up and GMP manufacturing of a second ... T-cell vaccine targeting folate receptor alpha. The manufactured ...
(Date:2/2/2017)... , Feb. 1, 2017  Central to its ... meaningful advances worldwide, The Japan Prize Foundation today ... who have pushed the envelope in their respective ... Communication. Three scientists are being recognized with the ... that not only contribute to the advancement of ...
(Date:1/31/2017)... Jan. 31, 2017  Spero Therapeutics, LLC, a ... the treatment of bacterial infections, today announced it ... candidates from Pro Bono Bio Ltd (PBB) to ... multi-drug resistant forms of Gram-negative bacteria.   The assets ... Ltd, a PBB group company. "The ...
Breaking Biology News(10 mins):
(Date:2/16/2017)... HACKENSACK, N.J. , Feb. 16, 2017  Champions ... engaged in the development and sale of advanced technology ... of oncology drugs, today announced the addition of new ... These new models will expand Champions, product ... cancer, head and neck cancer, AML, and non-small cell ...
(Date:2/16/2017)... and NEW YORK , Feb. 16, ... completion of their $7M Series B financing, adding an ... the $3.5M led by Mesa Verde Venture Partners and ... resources will be directed towards further accelerating commercial adoption ... comprehensive genomic profiling test and expanding the Paradigm cancer ...
(Date:2/15/2017)... , 15. Februar 2017  Trianni, Inc. ... Biotech, Inc. (Janssen) eine Lizenzvereinbarung über die Verwendung ... Klasse führenden Plattform für die Entdeckung monoklonaler Antikörper. ... ihr neuartiges chimäres Gensegmentdesign aus, das Janssen ... humanen Antikörpern bietet und das für die schelle ...
(Date:2/15/2017)... -- Windtree Therapeutics, Inc. (Nasdaq: WINT ), ... therapies for respiratory diseases, will host a conference call ... EST on Thursday, February 16, 2017 to provide updates ... announced closing of a $10.5 million private offering and ... in the live call and take part in the ...
Breaking Biology Technology: